You have read all your free articles, to continue reading subscribe to read the rest of this content.
Eir Ventures, a Nordic life science venture fund, has announced a first close of its new fund of EUR 76 million. With a base in the Nordic region and a team of experienced life science investors, Eir Ventures will invest in innovative companies with products and technologies addressing significanAlready a…
The company has announced an equity financing round of USD 1.6 million, bringing total pre-launch funding to $9 million. The two times oversubscribed financing round was led by Joyance Partners, a US-based venture capital firm, and Pär Gellerfors, one of the founders of the biotechnology companyAlready a subscriber Login You…
Just before Christmas Getinge announced an agreement to acquire 100% of the shares in Applikon Biotechnology. Applikon Biotechnology is a company in the area of advanced bioreactor systems for biopharmaceutical production and research, with an annual net sales of approximately SEK 450 million. Already a subscriber Login You have read…
Immunovia, Inc has received final approval to begin patient testing for the IMMray PanCan-d test. The IMMray PanCan-d test is the first blood test on the market dedicated to the early detection of pancreatic cancer. “We are extremely pleased to have achieved this important milestone and to bAlready a subscriber…
